GlassScriptPhysician profile
Barry Rodgers Davis
NPI 1295774925
$15,568.05
in general payments reported to CMS, 2019-2025
28 companies · $2,704 in 2025
The $2,704 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,296 · 2020: $1,637 · 2021: $1,505 · 2022: $2,820 · 2023: $3,032 · 2024: $2,574 · 2025: $2,704.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,062 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,061.93 |
| Travel and Lodging | $248.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $6,039.11 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryosphere Cryoablation System |
| Edwards Lifesciences Corporation | $2,662.27 | 2019-2025 | Mitris Resilia Mitral Valve, Konect Resilia, Evoque |
| Baxter Healthcare | $1,375.38 | 2022-2024 | Tisseel, Preveleak, Coseal |
| Cvrx, INC. | $1,244.92 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $869.72 | 2019-2025 | Lifevest |
| Abiomed | $795.74 | 2019-2025 | Impella |
| Getinge USA Sales, LLC | $730.49 | 2019-2023 | Cardiohelp |
| Elutia, INC. | $480.25 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $274.06 | 2019-2025 | Andexxa, Farxiga |
| Stryker Corporation | $168.56 | 2023 | Spy-Phi System |
| Abbott Laboratories | $122.68 | 2025 | Epic |
| Viiv Healthcare Company | $109.59 | 2025 | Apretude |
| Lsi Solutions INC | $108.90 | 2025 | Ram |
| La Jolla Pharmaceutical Company | $108.86 | 2021 | |
| Becton, Dickinson and Company | $97.02 | 2025 | Swan-Ganz |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $78.65 | 2022-2025 | |
| Davol INC. | $50.65 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $40.30 | 2024 | Onpattro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.32 | 2023 | Jardiance |
| Peerless Surgical INC. | $30.59 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $27.68 | 2022-2024 | Camzyos |
| Zoll Medical Corporation | $24.10 | 2025 | Defibrillator |
| Amgen INC. | $18.49 | 2024 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $15.63 | 2022 | |
| Merck Sharp & Dohme LLC | $15.49 | 2025 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $14.27 | 2024 | Arcalyst |
| Imbed Biosciences INC. | $13.94 | 2022 | |
| Solventum Corporation | $13.39 | 2024 | V.A.C.Instill |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.